Jasper Therapeutics, Inc.

NASDAQ:JSPR

6.01 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -21.241-24.321-18.637-14.583-13.728-16.581-17.544-16.08-14.26-13.211-11.863-10.404-2.207-9.057-3.412-8.414-9.754-9.987-0.011-0.009-0.001
Depreciation & Amortization 0.2790.2450.5410.2990.2880.2830.2760.2750.2740.2730.2680.2180.2160.1940.1320.0290.0220000
Deferred Income Tax 00000-0.8310000000-0.05-0.4503.5010000
Stock Based Compensation 1.8111.971.9981.4821.1691.1581.3951.3911.2671.6040.6441.0650.7780.2310.1950.2950.3270.437000
Change In Working Capital 00.8311.7191.002-3.601-1.4234.121.460.946-1.1711.7951.14-2.413-2.8872.6842.211-0.3870.125-00.001-0.001
Accounts Receivables 00000-0.663000.663-0.6630000000.0010000
Change In Inventory 00000-0.283000.2830.66300000000000
Change In Accounts Payables -1.0390.9570.2220.457-1.7580.8931.675-2.2652.078-1.3490.1751.476-2.4531.718-0.411.5470.083-1.244000
Other Working Capital 0-0.1261.4970.545-1.843-1.372.4453.725-2.0780.1781.62-0.3360.04-4.6053.0940.664-0.471.369-00.001-0.001
Other Non Cash Items 00.1410.3271.7433.6390.915-0.228-0.3181.438-0.141-0.487-1.375-10.587-3.015-6.2570.0880.0964.0320.0030.0050.001
Operating Cash Flow -22.842-21.134-14.052-11.68-15.736-16.479-11.981-13.272-10.335-12.646-9.643-9.356-14.213-14.584-7.108-5.791-6.195-5.393-0.008-0.003-0.001
Investing Activities:
Investments In Property Plant And Equipment 0-0.096-0.456-0.157-0.025-0.230-0.011-0.026-0.082-0.222-0.243-0.029-0.711-0.47-0.287-0.960000
Acquisitions Net 000000000000000000000
Purchases Of Investments 000000000000000000000
Sales Maturities Of Investments 000000000000000-0.1380.1380000
Other Investing Activites 0.0040.02-0.21800000000000-0.2180.2180.1380000
Investing Cash Flow 0.004-0.076-0.674-0.157-0.025-0.230-0.011-0.026-0.082-0.222-0.243-0.029-0.711-0.47-0.287-0.960000
Financing Activities:
Debt Repayment 000000000000000000000
Common Stock Issued 0-47.37647.1950.18147.1950.0280.0360.356101.4790.0280.0010.0130.01310.75101.878000000
Common Stock Repurchased 000.04500-00-0.00100.02800000000000
Dividends Paid 000000000000000000000
Other Financing Activities 047.540.0090.1810.154-0.2710.036-0.3050.0320.0280.0010.0130.013-0.90991.726-0.610.75210.803000.484
Financing Cash Flow 00.3450.0090.18147.349-0.2710.036-0.305101.5110.0280.0010.0130.013-0.90991.726-0.610.75210.803000
Other Information:
Effect Of Forex Changes On Cash 000000000000000000000
Net Change In Cash -22.838-20.865-14.317-11.65631.588-16.98-11.945-13.58891.15-12.7-9.864-9.586-14.229-16.20484.148-6.6783.5975.41-0.008-0.003-0.001
Cash At End Of Period 49.21672.05492.919106.819118.47586.887104.284116.229129.81738.66751.36761.23170.81785.046101.2517.10223.7820.1830.0150.0230.026